Improved HIV Drug Resistance Testing with Simple PCR Assays
Author Information
Author(s): Johnson Jeffrey A., Li Jin-Fen, Wei Xierong, Lipscomb Jonathan, Bennett Diane, Brant Ashley, Cong Mian-er, Spira Thomas, Shafer Robert W., Heneine Walid
Primary Institution: Centers for Disease Control and Prevention
Hypothesis
Can simple PCR assays improve the sensitivity of HIV-1 drug resistance testing?
Conclusion
The study demonstrates that sensitive real-time PCR testing can significantly enhance the detection of HIV-1 drug resistance mutations.
Supporting Evidence
- The new PCR assays can detect drug resistance mutations at frequencies as low as 0.3%.
- The assays were validated on a total of 302 samples with detectable drug resistance mutations.
- Detection limits for the assays were significantly lower than those of conventional sequencing methods.
- Real-time PCR assays showed sensitivities of 96% to >99% with highly polymorphic sequences.
- Sequencing mutation-specific amplicons revealed additional low-frequency mutations linked to targeted mutations.
Takeaway
This study shows that new tests can find tiny amounts of drug-resistant HIV that older tests might miss, helping doctors choose better treatments.
Methodology
The study developed real-time PCR assays for nine key drug resistance mutations and validated their sensitivity using clinical samples.
Limitations
The assays may not achieve the same sensitivity for all clinical samples due to low virus copy numbers or genomic differences.
Participant Demographics
The study included samples from individuals infected with HIV-1 in the US and Canada, collected between 1982-2005.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website